80
Participants
Start Date
July 31, 2023
Primary Completion Date
March 31, 2025
Study Completion Date
March 31, 2025
Darigabat
Oral tablets
Placebo
Oral tablets
New York, New York, New York
Staten Island, New York, Staten Island
Brooklyn, New York, Brooklyn
Brooklyn, New York, Brooklyn
Rochester, New York, Rochester
West Chester, Pennsylvania, West Chester
Monroe, North Carolina, Monroe
Decatur, Georgia, Decatur
Atlanta, Georgia, Atlanta
Savannah, Georgia, Savannah
Orlando, Florida, Orlando
North Miami Beach, Florida, North Miami Beach
Miami, Florida, Miami
Elgin, Illinois, Elgin
Overland Park, Kansas, Overland Park
Oklahoma City, Oklahoma, Oklahoma City
Desoto, Texas, DeSoto
Austin, Texas, Austin
Draper, Utah, Draper
Phoenix, Arizona, Phoenix
Las Vegas, Nevada, Las Vegas
Los Angeles, California, Los Angeles
Torrance, California, Torrance
Oceanside, California, Oceanside
Riverside, California, Riverside
Orange, California, Orange
Lafayette, California, Lafayette
San Jose, California, San Jose
Everett, Washington, Everett
Boston, Massachusetts, Boston
Berlin, New Jersey, Berlin
Lead Sponsor
AbbVie
INDUSTRY